The use of transgenic plants to express orally immunogenic protein antigens is an emerging strategy for vaccine biomanufacturing and delivery. This concept has particular suitability for developing countries. One factor that has limited the development of this technology is the relatively modest levels of accumulation of some antigenic proteins in plant tissues. We used fusion protein design to improve expression of the hepatitis B surface antigen (HBsAg) by attempting to mimic the process of HBsAg targeting to the endoplasmic reticulum of human liver cells during hepatitis B virus infection. We created a gene encoding a recombinant HBsAg modified to contain a plant signal peptide fused to its amino terminus. The signal peptide from soybean vegetative storage protein vspA (VSP␣S) directed endoplasmic reticulum targeting of HBsAg in plant cells, but was not cleaved and resulted in enhanced VSP␣S-HBsAg fusion accumulation. This product was more stable and presented the protective ''a'' antigenic determinant to significantly higher levels than unmodified native HBsAg expressed in plant cells. It also showed a greater extent of intermolecular disulfide bond formation and formation of virus-like particles. Moreover, VSP␣S-HBsAg stimulated higher levels of serum IgG than native HBsAg when injected into mice. We conclude that HBsAg tolerates a polypeptide fusion at the amino terminus and that VSP␣S-HBsAg is an improved antigen for plant-based expression of a subunit vaccine for hepatitis B virus.
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transgenic plants ͉ tobacco NT-1 cell ͉ vaccine H epatitis B virus (HBV) infection is an important global health problem, and vaccination is a proven strategy to control HBV infection. Current vaccines use yeast-derived recombinant hepatitis B surface antigen (rHBsAg) delivered by intramuscular injection, requiring trained medical practitioners and refrigerated storage, and are thus expensive to use. We have evaluated a new strategy for biomanufacturing the antigen to create a plant-derived oral vaccine, which could provide lower capital costs of production, mucosal immunization, and needlefree delivery of the final product. These advantages are particularly important for immunization programs in developing countries. Plant-derived HBsAg assembles into virus-like particles (VLPs) (1, 2) as in human (3), Chinese hamster ovary (4) , and yeast (5) cells. Potato-derived HBsAg is orally immunogenic in mice, but high doses are needed (2, 6) , creating a need for enhanced accumulation of the antigen in plant tissues if acceptable amounts of the plant material are to be delivered orally.
HBsAg is a transmembrane protein with uncleaved internal signal sequences that facilitate cotranslational translocation and integration of HBsAg into the endoplasmic reticulum (ER) membrane (7) . Subsequently, HBsAg dimers are rapidly formed via intermolecular disulfide bonds, catalyzed by protein disulfide isomerase (PDI). The protein-membrane complexes then assemble and extrude into the ER lumen (8) and are transported to the post-ER-pre-Golgi intermediate compartment, where further cross-linking to form higher-order oligomers occurs in the absence of PDI (9) . We previously showed that a plant ER signal peptide from the soybean gene vspA (VSP␣S) or an ER retention signal (KDEL) influenced HBsAg accumulation in transgenic potato (6) . The vspA gene has a 35-residue N-terminal pro sequence (10) , and the N-terminal 21 aa (VSP␣S) contain a predicted ER signal peptide (11) . The full 35-aa sequence (VSP␣L) also contains a putative vacuolar targeting peptide at its C terminus (10) . Proteins containing an ER retention signal (H͞KDEL) at the C terminus are returned to the ER via KDEL receptor in cis-Golgi (12) , and KDEL modification of the C terminus can enhance expression of the plant protein vicilin (13) in transgenic tobacco.
In this paper, we examine effects of plant ER-targeting motifs on HBsAg at the molecular level by using tobacco cells as a model. We show that the VSP␣S signal peptide significantly enhances HBsAg expression, ''a'' determinant formation, and VLP formation in NT-1 cells, resulting in a fusion protein VSP␣S-HBsAg that is more immunogenic in mice than the unmodified HBsAg.
Materials and Methods
Construction of Expression Plasmids. The synthetic plant-optimized DNA sequence encoding HBsAg (sHBsAg) subtype adr (GenBank accession no. AF504292; unpublished work) was modified by N-terminal extension with either a 21-aa (VSP␣S) or 35-aa (VSP␣L) plant ER signal peptide (10), and͞or C-terminal extension with the hexapeptide ''SEKDEL'' (6) . The coding sequences were under the control of enhanced cauliflower mosaic virus (CaMV) 35S promoter with the 5Ј UTR of the tobacco etch virus (TEV), and 3Ј UTR and polyadenylation signal from the soybean vegetative storage protein gene (vspB) (14) . The expression cassettes from HindIII to EcoRI were subcloned into pGPTV-KAN (15), a plant binary vector.
Plant Cell Transformation. The binary vectors were electroporated into Agrobacterium LBA4404, which were used to transform Nicotiana tabacum cv. Bright Yellow 2 (NT-1) cells (16) . Transformed calli were selected on NT-1 medium containing kanamycin and carbenicillin (Sigma) each at 300 mg͞liter, and randomly picked lines from each construct were maintained on NT-1 selective medium. The five highest-expression lines of each construct were placed into liquid suspension culture in shaker flasks at 25°C and 120 rpm and passed every 7 days. mM NaP i , pH 6.6͞100 mM NaCl͞10 mM EDTA, pH 8.0͞0.1% Triton X-100͞50 mM sodium ascorbate͞1 mM PMSF with Complete Protease Inhibitor (Roche, Indianapolis)]. Total HBsAg was assayed by polyclonal ELISA (17) Pulse-Chase Analysis and Immunoprecipitation. HBsAg stability experiments were performed as described (19) with some modifications. NT-1 cells (0.6 ml) at 7 days after passage were subcultured in 15 ml of NT-1 liquid medium. At day 5 after subculture, the cells were pulsed for 30 min with 133 Ci (1 Ci ϭ 37 GBq) of 35 S methionine͞cysteine protein labeling mix (NEN) per milliliter of culture cells. After the radioactive pulse, cells were washed three times with NT-1 medium and chased with 1 mM each unlabeled methionine and cysteine in NT-1 medium. At time points, 0.1 g of cells were collected and homogenized by Fastprep in 1 ml of HBsAg extracting buffer plus 10ϫ PBSTSD (4% Triton X-100͞2.5% deoxycholate͞0.5% SDS in 1ϫ PBS). For immunoprecipitation (IP, Fitzgerald Industries, Concord, MA), mouse monoclonal anti-HBsAg (Biogenesis, Poole, U.K.) was incubated with cell extracts (1 g͞1 mg total soluble protein) for 3 h on a rotor at 4°C. Then, a Protein G Plus-Agarose (Calbiochem) suspension was added and incubated at 4°C for 2 h. The protein G-antibody complexes were washed four times with 1ϫ PBSTSD and once with 10 mM Tris-acetate (pH 7.5), dried, and denatured with 6% SDS sample buffer containing 1 M DTT at 100°C for 10 min or 20 nM DTT at 37°C for 5 min.
Immunoprecipitates were subjected to SDS͞PAGE on 15% acrylamide gels, blotted to poly(vinylidene difluoride) (PVDF) membrane (Amersham Pharmacia), and probed with goat antiHBsAg (Fitzgerald Industries, Concord, MA). The blot was imaged with a Storm chemifluorescence system (Molecular Dynamics). For 35 S pulse-chase experiments, the gel was dried, detected with Storm system phosphor screen, and quantified with IMAGEQUANT software.
Sucrose Gradient and Concentrated Partially Purified NT-1-Derived
HBsAg. Sucrose gradients of crude plant cell extracts were performed as described (1) . Protein was extracted from NT-1 suspension culture cells by using 1 ml of extraction buffer (0.05% Triton X-100) per 0.1 g of cells (20) . Gradient fractions were subjected to polyclonal ELISA and Auszyme monoclonal assay. For mouse immunization, gradient fractions containing HBsAg were pooled, concentrated with Centriprep (Amicon), and kept at 4°C. A nontransgenic NT-1 cell extract was prepared in the same way for negative control.
Mouse Immunization. Antigens were adsorbed to Imject alum (Pierce) according to the manufacturer's instructions. BALB͞c mice (five mice per group) received i.p. injections of 490 g of alum-adsorbed particulate protein from nontransgenic NT-1 or 0.5 g of rHBsAg from yeast (Rhein Biotech, Düsseldorf, Germany), NT-1 cell line HB117, or NT-1 cell line HB118 (transgenic lines generated with constructs pHB117 and pHB118) on days 0 and 14. Tail blood was collected before each injection and every 2 weeks after the last injection. Serum antibodies against HBsAg were determined by endpoint titer ELISA and AUSAB EIA assay (Abbott) as described (2) . Geometric mean titer (GMT) was calculated using the reciprocal of the highest serum dilution that had an absorbance Ն0.1 OD unit above background. Anti-HBsAg IgG1 and IgG2a were determined by subisotyping with Mouse Typer Sub-Isotyping Kit (Bio-Rad) and 0.1 g per well of yeast rHBsAg.
Statistical Analysis. ANOVA for two-factor nested designs and Tukey-Kramer multiple comparison procedure at ␣ ϭ 0.05 were used to test least-squares means of HBsAg levels. Repeated measurement designs and Duncan's multiple range test were used in immune response analysis at ␣ ϭ 0.05.
Results

VSP␣S Plant Signal Peptide Enhanced HBsAg and ''a'' Determinant
Accumulation. NT-1 cells were transformed with plasmids ( Fig. 1) containing the plant-optimized sHBsAg coding sequence modified by N-terminal extension with vspA signal peptides and͞or C-terminal extension with an ER retention signal. Sixty-four independent lines of each construct were randomly sampled and tested for total HBsAg by polyclonal antibody ELISA and for ''a'' determinant by Auszyme monoclonal assay ( Table 1 ). The VSP␣S signal peptide significantly enhanced total HBsAg accumulation in HB118 lines as compared with HB117, the unmodified antigen. Modifications of HBsAg with VSP␣L or with the ER retention signal SEKDEL showed no significant enhancing effects on total HBsAg accumulation; HB123.1 (VSP␣L plus SEKDEL) actually showed significantly lower antigen accumulation ( Table 1) .
The five best lines from each construct (based on polyclonal ELISA) were selected for further study. The relative efficiency of ''a'' determinant formation for each construct was calculated as the percentage of ''a'' determinant in the total HBsAg. The HBsAg modified with VSP␣S in both HB118 and HB122.1 cell lines showed % ''a'' determinant at 35% and 46%, respectively, significantly higher than the unmodified form, HB117 (Table 1) . The modification of HBsAg with either VSP␣L or SEKDEL did not show any significant enhancing effect on ''a'' determinant formation.
We assayed ''a'' determinant in partially purified HBsAg stored at 4°C (later used for mouse immunization). The HB118 VSP␣S-HBsAg contained 53% ''a'' determinant at day 1 and remained stable until day 18 (Table 2 ). However, HB117 HBsAg contained 12% ''a'' determinant at day 1 and progressively increased to 55% at day 27. Total HBsAg measured by polyclonal ELISA remained fairly stable over the storage period for both constructs.
VSP␣S Signal Peptide Enhanced HBsAg Oligomerization and Stability.
HBsAg was immunoprecipitated from NT-1 cell extracts with monoclonal antibody against HBsAg, reduced with 1 M or 20 nM DTT, and run in 15% acrylamide gels. Despite the stringent reducing condition, yeast rHBsAg ( Fig. 2A, lane 1) showed a prominent dimer and weaker trimer band. HB117 (Fig. 2 A, lane  2) showed a monomer at the same mobility as the yeast rHBsAg but no evidence of oligomers. The band at Ϸ55 kDa was the immunoprecipitating IgG heavy chain cross-reacting with the anti-goat horseradish peroxidase (HRP) conjugate, which also occurred in nontransgenic NT-1 (Fig. 2 A, lane 8) . HB118 showed distinct monomer, dimer, trimer, and tetramer bands (Fig. 2 A, lane 3) . Both VSP␣S-modified HB118 and HB122.1 monomers (Fig. 2 A, lanes 3 and 6, respectively) ran slower than yeast rHBsAg at a position consistent with the size of HBsAg extended by the uncleaved VSP␣S signal peptide (adding Ϸ2.4 kDa). Both VSP␣L-modified HB119 (Fig. 2 A, lane 4) and HB123.1 (Fig. 2 A, lane 7) showed partial processing to form the monomer comigrating with yeast rHBsAg (HB119) or slightly larger (HB123.1). Interestingly, HB119 showed only a faint dimer, whereas the SEKDEL-modified HB123.1 showed prominent dimer, trimer, and tetramer bands. Thus, HB118, HB122.1, and HB123.1 extracts showed more extensive disulfide-mediated oligomerization than HB117, HB119, and HB121.1. When samples were run at a slight reducing condition (20 nM DTT), the dimer was the most prominent form in HB117 unmodified and HB119 VSP␣L-modified HBsAg (Fig. 2B, lanes 2 and 4, respectively) , whereas the HB118 VSP␣S-modified HBsAg showed strong dimer, trimer, tetramer, and higher-order oligomers that barely penetrated the resolving gel (Fig. 2B, lane 3) . These data indicate that oligomer formation resulted from enhanced intermolecular disulfide bond formation in VSP␣S-modified HBsAg.
Because the signal peptide remained uncleaved, the VSP␣S-modified HBsAg construct produced a fusion protein in plant cells. To determine whether the VSP␣S-HBsAg fusion protein was more stable in plant cells, we studied HBsAg antigen degradation rates with 35 S pulse-chase experiments. The HB117 unmodified HBsAg showed a half-life of Ϸ68 h (Fig. 3) . In contrast, we could detect no degradation of the VSP␣S-HBsAg fusion protein for up to 72 h of chase period. The slope of the HBsAg levels (ng͞mg TSP) were from duplicate assays in three independent experiments by polyclonal ELISA and % ''a'' determinant was calculated as (HBsAg by Auszyme assay)͞(HBsAg by polyclonal ELISA) in two independent experiments. Tukey's studentized range test at ␣ ϭ 0.05 was used to test least-squares means of HBsAg and least-squares means of % ''a'' determinant. The superscript letters indicate the significant differences between constructs; data with the same letter indicated are not significantly different at ␣ ϭ 0.05. HBsAg was measure by either polyclonal ELISA or Auszyme monoclonal assay; % ''a'' epitope is calculated as in Table 1 . ND, not determined. 
APPLIED BIOLOGICAL SCIENCES
HB117 degradation rate was significantly different from that of HB118 at P ϭ 0.0002, using analysis of covariance. HBsAg expressed in potato assembles VLPs that accumulate in ERderived vesicles (2) . To determine the VLP nature of the VSP␣S-HBsAg fusion protein, we performed sucrose gradient sedimentation experiments with HB117 and HB118 NT-1 cell extracts compared with yeast HBsAg. Both NT-1 lines showed polyclonal antibody-reactive antigen that cosedimented with the peak of the yeast rHBsAg (Fig. 4A) . The HB118 VSP␣S-HBsAg showed a somewhat broader peak than unmodified HB117 but did not display the faster-sedimenting shoulder produced by yeast rHBsAg. The HB118 profile of Auszyme monoclonalreactive antigen (Fig. 4B ) did show such a shoulder in fraction 8, and furthermore showed much greater reactivity in all particulate fractions than did the unmodified HB117 HBsAg.
VSP␣S-HBsAg Fusion Protein Is a More Potent Immunogen than
Unmodified HBsAg. We tested the immunogenicity of partially purified extracts of NT-1 cell lines by i.p. injection in mice at days 0 and 14. Although our ultimate goal is oral delivery of a plant-derived vaccine, the aim of this experiment was to evaluate the immunogenic potential of the two antigen forms in a manner as precise as possible. Mice that received two 0.5-g doses of alum-adsorbed yeast recombinant HBsAg showed very high titers for both AUSAB EIA assay [mean ϭ 5,154 milliinternational units (mIU)/ml at day 56] and endpoint titer (GMT ϭ 704,636 at day 70). Mice that received HB117-unmodified HBsAg showed a GMT of 2,868 (five of five responding) at day 70 but only three of five showed an immune response higher than the protective limit (Ͼ10 mIU͞ml) at day 56, with a mean of 12 mIU͞ml (Fig. 5 A and B) . The HB118 VSP␣S-HBsAg fusion protein produced AUSAB responses in five of five mice (mean ϭ 115 mIU͞ml at day 56, GMT ϭ 8,390 at day 70). The yeast rHBsAg caused antibody responses within 14 days after the first dose, with the anti-HBsAg reaching peak levels at 40 days and then leveling off (Fig. 5) . The HB118 VSP␣S-HBsAg mice reached the protective level of 10 mIU͞ml in 42 days, but the HB117 HBsAg mice required 56 days to reach this level (Fig. 5B) . The responses to HB117 HBsAg leveled off at day 56, but for HB118 both ELISA GMT and AUSAB titer responses continued to increase to day 70. Mice that received alum-adsorbed, partially purified total soluble protein from nontransgenic NT-1 cells showed no significant immune responses. The HB118 responses were significantly higher than those of HB117, as determined by Duncan's multiple range test at ␣ ϭ 0.05. We examined the sera from immunized mice for IgG subtypes IgG1 and IgG2a (Fig. 6) . The yeast rHBsAg induced more rapid and higher responses than either plant cell-derived antigen, but the HB118 VSP␣S-HBsAg showed higher levels of both subtypes than HB117 unmodified HBsAg. Furthermore, the IgG1͞IgG2a ratios obtained using HB118 antigen were much more similar to those obtained using the yeast rHBsAg.
Discussion
VSP␣S Plant Signal Peptide Enhanced HBsAg Accumulation in Trans-
genic NT-1 Cells. HBsAg is a transmembrane protein that is synthesized, transported, and undergoes posttranslational modifications (disulfide bond formation and glycosylation), via the secretory pathway. To increase HBsAg accumulation in transgenic plant systems, we evaluated plant signal peptides and͞or the ER retention signal SEKDEL for effects on expression and assembly of immunogenic HBsAg. The results show significantly enhanced expression of the VSP␣S-HBsAg fusion protein (Table 1). If HBsAg signal I does not fully function in plant cells, some of the nascent chains may fold incorrectly in the reducing environment of the cytoplasm. Therefore, inefficient ER targeting could result in poor HBsAg accumulation in the plant system, as was observed with hordothionins expressed in transgenic tobacco (21) . There is evidence in other systems that the host signal peptide functions more efficiently than a transgene's native signal peptide (22) , findings consistent with our data on HBsAg expression. Conversely, VSP␣L-modified HBsAg (HB119 and HB123.1) had a negative effect on HBsAg accumulation (Table 1) . Because the VSP␣L signal peptide contains the same N-terminal sequence as the VSP␣S peptide, the putative vacuolar-targeting signal in the C terminus of VSP␣L (10) might lead VSP␣L-modified HBsAg to lytic vacuoles where protein degradation occurs (23), and thus limit accumulation of antigen.
The modification of HBsAg with ER retention signal, SEKDEL, showed no enhancing effects on HBsAg accumulation. However, an ER retention signal can retard protein transit through the ER yet be insufficient for protein retention in the ER (24) . Further, HBsAg accumulates in post-ER-pre-Golgi intermediate compartments in Chinese hamster ovary cells (4), yeast cells (5), and plant cells (2) . Thus, the recombinant antigen might never reach the KDEL receptor located in cis-Golgi (12) , making the retention signal superfluous. This result is inconsistent with our previous findings in transgenic potato plants, where a marginal enhancement of HBsAg expression was found by using the native HBsAg gene extended with SEKDEL at the C terminus. Differences in the cellular sorting machinery in potato leaf versus NT-1 cells may account for this slight discrepancy.
VSP␣S Plant Signal Peptide Enhanced Oligomerization, ''a'' Determinant Formation, and Stability of HBsAg. The ''a'' determinant is a common antigenic determinant found in all hepatitis B virus (HBV) subtypes (25), thus providing cross protection. Disulfide bonding (intra-and intermolecular) plays an important role in HBsAg stability, correct antigenic determinant formation, and VLP assembly (26) . We show here that extension of the HBsAg N terminus with an uncleaved VSP␣S signal peptide enhanced intermolecular disulfide bond formation in plant cells, resulting in higher-order oligomer formation than with unmodified HBsAg (Fig. 2) . The VSP␣S-HBsAg fusion protein was also more stable in NT-1 cells (Fig. 3) and showed a significantly higher proportion of ''a'' determinant than unmodified form ( Table 1 ). The VSP␣S-HBsAg contained 53% of ''a'' determi- nant soon after extraction, whereas the unmodified HBsAg gradually increased to 55% of ''a'' determinant after 27 days in storage ( Table 2 ). The observation that total HBsAg was stable during the storage period for both constructs suggests that the accumulating ''a'' determinant in HB117 material resulted from modification of the polypeptides in vitro, perhaps by oxidation to form correct disulfide bonds. This idea is supported by the observation that the reducing agent sodium ascorbate inhibits in vitro formation of ''a'' determinant and oligomerization of HBsAg in extracts of NT-1 cells (20) . These data suggest three possible mechanisms for the observed effects of the plant signal peptide. First, if the VSP␣S peptide did enhance HBsAg targeting to the ER, the increased antigen concentration could enhance oligomerization and stability, as observed for influenza virus hemagglutinin (27) . Second, VSP␣S might directly affect folding of the HBsAg polypeptide, thus enhancing correct disulfide bond formation. The uncleaved VSP␣S peptide is likely to form another hydrophobic transmembrane domain (28) that could attract the native transmembrane domains by hydrophobic interaction. Third, the cysteine residue in the VSP␣S peptide, which is located outside the predicted helical transmembrane motif (28) , might act as an internal chaperone to facilitate disulfide bond formation and protein folding. This mechanism was observed with a cysteine residue in the pro region of bovine pancreatic trypsin inhibitor that assists disulfide bond formation and folding (29) .
The accumulation of VSP␣S-HBsAg fusion in NT-1 cells indicates that amino acid fusions at the N terminus did not interfere with antigenic determinant formation, because VSP␣S-HBsAg could be immunoprecipitated with monoclonal antibody specific to the ''a'' determinant and even increased the proportion of HBsAg detectable with the Auszyme monoclonal assay. The uncleaved signal did not interfere with VLP formation and actually enhanced ''a'' determinant in fast-sedimenting sucrose gradient fractions, compared with unmodified HBsAg (Fig. 4) . The lack of cleavage of the VSP␣S signal peptide might be due to poor presentation of the processing site to signal peptidase. The longer VSP␣L signal peptide was partially processed (Fig. 2) , perhaps because the linker between the two transmembrane domains allowed protrusion of the cleavage site from the ER membrane surface.
VSP␣S-HBsAg Was More Immunogenic than Unmodified HBsAg. We showed here that mice immunized with the HB118 VSP␣S-HBsAg had stronger antibody responses and greater numbers of responders than mice that received the HB117 unmodified HBsAg (Fig. 5B) . The yeast recombinant rHBsAg provoked an antibody response (mIU͞ml) 106 times and 11 times stronger than tobacco cell-derived HB117 HBsAg and HB118 VSP␣S-HBsAg, respectively (Fig. 5) . Although we injected all mice with equal amounts of total HBsAg (as determined by polyclonal ELISA), the relative proportion of correctly folded antigen ( Table 2 , % ''a'' epitope) and the level of subunit oligomerization (Fig. 2) were lower in the plant material, especially in unmodified HBsAg from HB117 cells. Furthermore, the plant extracts were only partially purified, and thus contained contaminants that might interfere with antigen processing or presentation in mice.
In mice, Th1 lymphocytes stimulate production of complement-fixing IgG subtypes (e.g., IgG2a) and cell-mediated immune responses, whereas Th2 cells stimulate noncomplement fixing IgG subtype (e.g., IgG1) production and promote humoral immune responses (30, 31) . Therefore, the mouse IgG1͞IgG2a profile is usually used as an indicator of the Th1-versus Th2-biased immune response. Both the yeast rHBsAg and VSP␣S-modified HBsAg induced relatively balanced immune responses (ratio near 1.0), whereas the unmodified HBsAg induced a more Th2-biased response. Alum is an adjuvant that can induce a strong Th2 response (32) and probably contributed to this effect. The early IgG1 responses were followed by increasing levels of IgG2a; however, HB117 cell antigen caused a lower IgG2a response than did either the yeast rHBsAg or HB118 VSP␣S-HBsAg.
In conclusion, our results indicate that the VSP␣S-HBsAg was a more efficient immunogen than the unmodified HBsAg expressed in plant cells. The enhanced immunogenicity of the VSP␣S-HBsAg fusion probably results from the observed increase in oligomerization, antigen stability, and ''a'' determinant presentation in plant cells.
